APA (7th ed.) Citation

EL, M., N, T., S, R., JJ, S., DR, S., 3rd, B. H., . . . HJ, B. (2024). A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer. Breast cancer research and treatment, 204(1), 123. https://doi.org/10.1007/s10549-023-07167-9

Chicago Style (17th ed.) Citation

EL, Mayer, et al. "A Randomized Phase II Study of Metronomic Cyclophosphamide and Methotrexate (CM) with or Without Bevacizumab in Patients with Advanced Breast Cancer." Breast Cancer Research and Treatment 204, no. 1 (2024): 123. https://doi.org/10.1007/s10549-023-07167-9.

MLA (9th ed.) Citation

EL, Mayer, et al. "A Randomized Phase II Study of Metronomic Cyclophosphamide and Methotrexate (CM) with or Without Bevacizumab in Patients with Advanced Breast Cancer." Breast Cancer Research and Treatment, vol. 204, no. 1, 2024, p. 123, https://doi.org/10.1007/s10549-023-07167-9.